Schwann cell-associated early α-synuclein aggregation in skin biopsies of multiple system atrophy patients
This study demonstrates that skin biopsies from multiple system atrophy patients exhibit distinct Schwann cell-associated α-synuclein aggregates, offering a potential peripheral biomarker to help differentiate this condition from Parkinson's disease despite moderate diagnostic accuracy.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The brain is a complex network of cells that communicate to keep the body moving and thinking. In a group of disorders known as synucleinopathies, a specific protein called alpha-synuclein, which normally helps cells function, begins to clump together in harmful ways. In Parkinson's disease, these clumps form inside nerve cells, while in a related but distinct condition called multiple system atrophy, the clumps are found primarily inside the support cells that wrap around nerves. Because the symptoms of these diseases often look very similar in the early stages—such as stiffness, balance issues, and problems with automatic body functions like blood pressure—doctors frequently struggle to tell them apart while a patient is still alive. This uncertainty can lead to incorrect diagnoses and treatments that do not fit the patient's specific needs. Scientists have long looked for a way to spot these differences early, hoping to find a biological sign that is unique to each disease, perhaps by examining tissues outside the brain where the disease might leave its mark first.
A team of researchers in Italy recently took a closer look at the skin to see if they could find these distinct biological signatures. They focused on alpha-synuclein clumps, specifically looking for small, early versions of these aggregates that form before they grow into larger, insoluble masses. The team collected tiny samples of skin from the forearms of eighty-two people: thirty-one patients with multiple system atrophy, twenty-seven with Parkinson's disease, and twenty-four healthy volunteers who served as a baseline for comparison. Using a highly sensitive technique that acts like a molecular spotlight to reveal when two alpha-synuclein proteins are touching each other, the researchers examined the skin samples under a microscope. They were particularly interested in two areas: the tiny nerve endings that control sweating and the larger nerve bundles that run through the skin, paying close attention to the support cells, known as Schwann cells, that wrap around these nerves.
The investigation revealed that both groups of patients had higher levels of these early protein clumps in their nerve endings compared to the healthy volunteers, confirming that this is a shared feature of the disease process. However, a crucial difference emerged when the researchers looked at the support cells surrounding the nerves. In the patients with multiple system atrophy, these support cells were filled with the early protein clumps, a finding that was significantly more common and abundant than in the patients with Parkinson's disease. While the healthy volunteers showed almost no signs of these clumps in their support cells, the Parkinson's group showed some presence, but the multiple system atrophy group showed a much stronger signal. In fact, every single patient with multiple system atrophy had at least one nerve in their skin sample where these support cells were affected, whereas this was not the case for all Parkinson's patients.
The researchers also found that the amount of these clumps in the nerve endings seemed to relate to how well patients performed on tests of thinking and planning, particularly in the group with multiple system atrophy. This suggests that the biological changes happening in the skin are connected to the broader health of the nervous system. While the method used to distinguish between the two diseases was not perfect on its own—meaning it could not definitively diagnose a patient in every single case—the results provide a new and important piece of the puzzle. The study demonstrates that the skin can serve as a window into the nervous system, revealing that the disease process in multiple system atrophy involves the support cells of the nerves much more heavily than in Parkinson's disease. This discovery offers a potential path toward better diagnostic tools that could help doctors identify the correct condition earlier, allowing for more tailored care for patients facing these challenging neurodegenerative disorders.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.